rs2076584
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_018993.4(RIN2):c.1818C>T(p.His606His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.328 in 1,596,974 control chromosomes in the GnomAD database, including 92,739 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.35 ( 10187 hom., cov: 33)
Exomes 𝑓: 0.33 ( 82552 hom. )
Consequence
RIN2
NM_018993.4 synonymous
NM_018993.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.255
Publications
21 publications found
Genes affected
RIN2 (HGNC:18750): (Ras and Rab interactor 2) The RAB5 protein is a small GTPase involved in membrane trafficking in the early endocytic pathway. The protein encoded by this gene binds the GTP-bound form of the RAB5 protein preferentially over the GDP-bound form, and functions as a guanine nucleotide exchange factor for RAB5. The encoded protein is found primarily as a tetramer in the cytoplasm and does not bind other members of the RAB family. Mutations in this gene cause macrocephaly alopecia cutis laxa and scoliosis (MACS) syndrome, an elastic tissue disorder, as well as the related connective tissue disorder, RIN2 syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2011]
RIN2 Gene-Disease associations (from GenCC):
- RIN2 syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Orphanet, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 20-19990061-C-T is Benign according to our data. Variant chr20-19990061-C-T is described in ClinVar as Benign. ClinVar VariationId is 257654.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.255 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.693 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RIN2 | NM_018993.4 | c.1818C>T | p.His606His | synonymous_variant | Exon 10 of 13 | ENST00000255006.12 | NP_061866.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RIN2 | ENST00000255006.12 | c.1818C>T | p.His606His | synonymous_variant | Exon 10 of 13 | 2 | NM_018993.4 | ENSP00000255006.7 | ||
| RIN2 | ENST00000440354.2 | c.519C>T | p.His173His | synonymous_variant | Exon 5 of 8 | 1 | ENSP00000391239.2 | |||
| RIN2 | ENST00000484638.1 | n.1662C>T | non_coding_transcript_exon_variant | Exon 6 of 9 | 1 | |||||
| RIN2 | ENST00000648440.1 | c.1818C>T | p.His606His | synonymous_variant | Exon 9 of 12 | ENSP00000498085.1 |
Frequencies
GnomAD3 genomes AF: 0.354 AC: 53782AN: 152008Hom.: 10172 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
53782
AN:
152008
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.368 AC: 82119AN: 223160 AF XY: 0.353 show subpopulations
GnomAD2 exomes
AF:
AC:
82119
AN:
223160
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.325 AC: 469719AN: 1444848Hom.: 82552 Cov.: 34 AF XY: 0.322 AC XY: 230974AN XY: 716884 show subpopulations
GnomAD4 exome
AF:
AC:
469719
AN:
1444848
Hom.:
Cov.:
34
AF XY:
AC XY:
230974
AN XY:
716884
show subpopulations
African (AFR)
AF:
AC:
12725
AN:
33174
American (AMR)
AF:
AC:
24242
AN:
41868
Ashkenazi Jewish (ASJ)
AF:
AC:
8803
AN:
25770
East Asian (EAS)
AF:
AC:
29038
AN:
39088
South Asian (SAS)
AF:
AC:
20633
AN:
83584
European-Finnish (FIN)
AF:
AC:
12746
AN:
52576
Middle Eastern (MID)
AF:
AC:
1485
AN:
5752
European-Non Finnish (NFE)
AF:
AC:
339735
AN:
1103186
Other (OTH)
AF:
AC:
20312
AN:
59850
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
15929
31858
47788
63717
79646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
11434
22868
34302
45736
57170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.354 AC: 53832AN: 152126Hom.: 10187 Cov.: 33 AF XY: 0.354 AC XY: 26341AN XY: 74374 show subpopulations
GnomAD4 genome
AF:
AC:
53832
AN:
152126
Hom.:
Cov.:
33
AF XY:
AC XY:
26341
AN XY:
74374
show subpopulations
African (AFR)
AF:
AC:
16032
AN:
41482
American (AMR)
AF:
AC:
7213
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
1147
AN:
3472
East Asian (EAS)
AF:
AC:
3681
AN:
5170
South Asian (SAS)
AF:
AC:
1226
AN:
4828
European-Finnish (FIN)
AF:
AC:
2442
AN:
10576
Middle Eastern (MID)
AF:
AC:
80
AN:
292
European-Non Finnish (NFE)
AF:
AC:
20954
AN:
67986
Other (OTH)
AF:
AC:
799
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1777
3554
5332
7109
8886
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
526
1052
1578
2104
2630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1616
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sep 29, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
RIN2 syndrome Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.